0001415889-24-007503.txt : 20240311
0001415889-24-007503.hdr.sgml : 20240311
20240311161538
ACCESSION NUMBER: 0001415889-24-007503
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240308
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tasse Daniel
CENTRAL INDEX KEY: 0001502785
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36697
FILM NUMBER: 24738219
MAIL ADDRESS:
STREET 1: C/O IKARIA, INC.
STREET 2: 6 STATE ROUTE 173
CITY: CLINTON
STATE: NJ
ZIP: 08809
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DBV Technologies S.A.
CENTRAL INDEX KEY: 0001613780
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: I0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 177-181 AVENUE PIERRE BROSSOLETTE
CITY: MONTROUGE
STATE: I0
ZIP: 92120
BUSINESS PHONE: 33(0)155427878
MAIL ADDRESS:
STREET 1: 177-181 AVENUE PIERRE BROSSOLETTE
CITY: MONTROUGE
STATE: I0
ZIP: 92120
4
1
form4-03112024_040312.xml
X0508
4
2024-03-08
0001613780
DBV Technologies S.A.
DBVT
0001502785
Tasse Daniel
C/O DBV TECHNOLOGIES S.A.
177-181 AVENUE PIERRE BROSSOLETTE
MONTROUGE
I0
92120
FRANCE
true
true
false
false
CHIEF EXECUTIVE OFFICER
0
Ordinary Shares
2024-03-08
4
P
0
17094
0.83
A
17094
D
The Ordinary Shares may be represented by American Depositary Shares ("ADS"), each of which currently represents one-half of one Ordinary Share.
Represent the ADS price.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8123 to $0.8612 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Jason Minio, Attorney-in-Fact
2024-03-11